Delivery Order SPE2DB20D2014-SPE2DB25FB41G

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.76 firm-fixed-price delivery order is for the supply of 100 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,454.05 for the supply of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.40 firm fixed-price delivery order is for the supply of 100 units of 50 mg Vyvanse capsules. The contract has an ultimate completion date of January 16, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,344 firm fixed-price delivery order is for the supply of Vyvanse 30mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,031.88 firm fixed-price delivery order is for the supply of 4,566,242 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,098.39 delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, covers the supply of Vyvanse 40 mg capsules to support military healthcare programs. The IDC, which runs through November 2026, enables the DLA to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.55 firm fixed-price delivery order is for the supply of Vyvanse 50 mg capsules (100-count) to support military and federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.42 Firm Fixed Price delivery order covers the supply of 100 capsules of the medication Vyvanse 70 mg. This award is a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of...
This federal contract award, valued at $1,024.45, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through November 2024, is for the delivery of Vyvanse 10 mg capsules in 100-count packages. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,476.81 firm-fixed-price delivery order is for the supply of Vyvanse 10 mg capsules. The award does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB41G
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,108.50 firm fixed-price delivery order is for the supply of Vyvanse 10 mg capsules to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to the military. This IDC serves as a primary contracting vehicle for critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/21/25, 9:49 AM